End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 TWD | -12.30% | -27.03% | -59.88% |
18/04 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 634M 19.45M 1.62B | Sales 2023 | 649M 19.9M 1.66B | Capitalization | 4.1B 126M 10.47B |
---|---|---|---|---|---|
Net income 2022 | 47M 1.44M 120M | Net income 2023 | - 0 0 | EV / Sales 2022 | 8.97 x |
Net Debt 2022 | 119M 3.65M 304M | Net Debt 2023 | 160M 4.91M 409M | EV / Sales 2023 | 6.56 x |
P/E ratio 2022 |
116
x | P/E ratio 2023 |
5,009
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 27.77% |
1 day | -12.30% | ||
1 week | -27.03% | ||
Current month | -50.53% | ||
1 month | -51.06% | ||
3 months | -58.69% | ||
6 months | -53.97% | ||
Current year | -59.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 03/18/03 |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 11/16/11 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Hsiang Chen
CEO | Chief Executive Officer | - | 03/18/03 |
Ping-Ho Yan
BRD | Director/Board Member | - | - |
Pai Feng Wu
PRN | Corporate Officer/Principal | - | 31/14/31 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 13.9 | -12.30% | 2,051,385 |
25/24/25 | 15.85 | +15.69% | 2,792,125 |
24/24/24 | 13.7 | -1.79% | 2,649,284 |
23/24/23 | 13.95 | -11.99% | 7,921,550 |
22/24/22 | 15.85 | -16.80% | 3,165,588 |
End-of-day quote Taipei Exchange, April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-59.88% | 50.36M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 6562 Stock